Kala Bio (KALA) Operating Leases (2021 - 2025)
Kala Bio (KALA) posted Operating Leases of $1.1 million for Q3 2025, down 9.37% sequentially from $1.2 million in Q2 2025, and down 27.42% YoY from $1.5 million in Q3 2024.
Kala Bio (KALA) Operating Leases (2021 - 2025) Analysis & Trends
Kala Bio has reported Operating Leases for 4 years, with the latest figure at $1.1 million in Q3 2025.
- Quarterly Operating Leases fell 27.42% year-over-year to $1.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 27.42% YoY) and the FY2024 annual result came in at $1.4 million, down 20.29% from the prior year.
- Operating Leases slipped to $1.1 million in Q3 2025 per KALA's latest filing, from $1.2 million in the prior quarter.
- Over five years, Operating Leases peaked at $1.9 million in Q3 2023 and troughed at $548000.0 in Q4 2021.
- A 4-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases declined 18.51% in 2024, then retreated 27.42% in 2025.
- Over 4 years, Operating Leases stood at $548000.0 in 2021, then surged by 228.28% to $1.8 million in 2023, then dropped by 20.29% to $1.4 million in 2024, then dropped by 22.45% to $1.1 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $1.1 million, $1.2 million, and $1.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Dec 31, 2021 | 548,000.00 |